Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results from ORBITA-2 | JACC episode artwork

EPISODE · May 5, 2025 · 9 MIN

Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results from ORBITA-2 | JACC

from JACC This Week

In this podcast, Dr. Valentin Fuster discusses a groundbreaking study from the Orbiter 2 trial, which explores how dobutamine stress echocardiography (DSE) can predict the efficacy of percutaneous coronary intervention (PCI) in relieving angina in patients with stable coronary artery disease. The study reveals that the degree of ischemia, as measured by DSE, is strongly correlated with improvement in symptoms, offering new insights into patient selection for PCI treatment.

Episode metadata supplied by the publisher feed · Published May 5, 2025

Embed this episode

NOW PLAYING

Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results from ORBITA-2 | JACC

0:00 9:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JACC This Week?

This episode is 9 minutes long.

When was this JACC This Week episode published?

This episode was published on May 5, 2025.

Can I download this JACC This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!